Related Experiment Videos
Lomefloxacin clinical pharmacokinetics
C D Freeman1, D P Nicolau, P P Belliveau
1Department of Pharmacy, Hartford Hospital, Connecticut.
Clinical Pharmacokinetics
|July 1, 1993
Summary
Lomefloxacin, a quinolone antibiotic, offers convenient dosing due to its pharmacokinetics. Its favorable safety profile and minimal drug interactions make it a valuable option in specific clinical situations.
Area of Science:
- Pharmacology
- Microbiology
- Drug Development
Background:
- Lomefloxacin is a quinolone antibiotic with properties similar to other agents in its class.
- Variations in antimicrobial activity exist between lomefloxacin and other quinolones, typical for antibiotic classes.
Purpose of the Study:
- To evaluate the pharmacokinetic properties of lomefloxacin.
- To assess the clinical utility of lomefloxacin based on its safety and drug interaction profile.
Main Methods:
- Pharmacokinetic analysis of lomefloxacin, including serum concentrations and half-life.
- Evaluation of drug interactions, particularly with heavy metals and in patients with renal or liver dysfunction.
- Assessment of antimicrobial activity against specific microorganisms.
Main Results:
- Lomefloxacin exhibits pharmacokinetics supporting once- or twice-daily dosing due to high serum concentrations and long half-life.
- Key pharmacokinetic features include high tissue distribution, minimal metabolism (avoiding common drug interactions), and good oral absorption.
- Interactions with heavy metals can be managed by administration timing; dosage adjustments are needed for renal dysfunction but not liver disease.
Conclusions:
- Lomefloxacin demonstrates favorable pharmacokinetic properties, including convenient dosing and minimal metabolic drug interactions.
- Its safety profile, ease of administration, and manageable interactions position lomefloxacin as a useful antibiotic in specific clinical contexts.